Fig. 5
From: The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation – quo vadis?
Exemplary cardiovascular magnetic resonance images in the long-axis view of a study patient with a septal myocardial infarction who underwent pre-Feraheme™ (FH) (baseline) and post-Feraheme™ (after 6, 24, 48 h) cardiovascular magnetic resonance imaging studies, respectively. The first line shows cine-cardiovascular magnetic resonance images at different time points with proof of hyperenhancement in the septal wall at 6–48 h post-Feraheme™ (red arrows). The second line shows T2-weighted short-tau inversion recovery-spin echo images at different time points with proof of hypoenhancement in the septal wall at 6–48 h post-Feraheme™ (red arrows). Reproduced with permission from Yilmaz et al. [57]